Related Experiment Video
Updated: Feb 20, 2026

Author Spotlight: Novel Assay for Studying B-Cell Responses in Multiple Sclerosis Research
Published on: December 1, 2023
Human endogenous retroviruses in the aetiology of MS
1Department of Biomedicine, Aarhus University, Aarhus, Denmark.
Abstract:
Several lines of investigation have provided strong indications for an association between the immune-mediated, neurologic disease multiple sclerosis (MS) and human endogenous retroviruses (HERVs). Whether the relationship is causal is yet to be established. Endogenous retroviruses are pathogenic-in other species than the human. Several aspects of the activation and involvement of specific HERV families (HERV-H/F and HERV-W/MSRV) have been documented, both for cells in the periphery and in the central nervous system. Specific HERV-encoded genes and certain gene products (envelope proteins, Envs) appear strongly associated with the disease and have pathogenic potential. Most HERV sequences are non-functional, whereas some HERV loci have coding potential but remain quiescent in non-pathological conditions, so the importance of regulatory pathways and epigenetics involved in regulating HERV activation, de-repression, and also involvement of retroviral restriction factors, is emerging. Disease intervention by means of antiretrovirals has potential as a novel therapeutic strategy in MS treatment; this is compounded by the apparently reduced risk of MS in HIV infection as a consequence of therapy. Extensive studies of HERVs, their role in neurologic diseases, and their potential as therapeutic targets are needed.
Insights
Investigating human endogenous retroviruses (HERVs) in multiple sclerosis (MS) reveals potential links. HERV activation and specific proteins may play a role in MS pathogenesis, suggesting novel therapeutic targets.
Area of Science:
- Neurology
- Immunology
- Virology
Background:
- Multiple sclerosis (MS) is an immune-mediated neurologic disease with suspected links to human endogenous retroviruses (HERVs).
- HERVs are retroviral sequences integrated into the human genome, some of which are implicated in disease pathology in other species.
- Specific HERV families (e.g., HERV-H/F, HERV-W/MSRV) show activation in MS patients' nervous systems and peripheral cells.
Purpose of the Study:
- To explore the association between HERVs and multiple sclerosis.
- To investigate the pathogenic potential of HERV-encoded genes and proteins in MS.
- To highlight the role of regulatory pathways, epigenetics, and restriction factors in HERV activation relevant to MS.
Main Methods:
- Review of existing research on HERV involvement in neurological diseases.
- Analysis of documented HERV family activation in the central nervous system and periphery of MS patients.
- Examination of the potential pathogenic role of HERV envelope proteins (Envs).
Main Results:
- Strong indications of an association between MS and HERVs, particularly specific families like HERV-H/F and HERV-W/MSRV.
- HERV-encoded genes and envelope proteins show strong association with MS and possess pathogenic potential.
- Emerging evidence points to the importance of epigenetic regulation and restriction factors in controlling HERV activation.
Conclusions:
- HERVs are strongly implicated in multiple sclerosis, with specific HERV elements potentially contributing to disease pathogenesis.
- Understanding HERV regulation is crucial for elucidating their role in MS.
- Antiretroviral therapies targeting HERVs represent a promising novel therapeutic strategy for MS, supported by observations in HIV-infected individuals.
More Related Videos
Related Concept Videos
Retroviruses
Non-LTR Retrotransposons
Mechanisms of Retrovirus-induced Cancers
Retrovirus Life Cycles
Rous Sarcoma Virus (RSV) and Cancer
RSV is a retrovirus that contains two copies of a plus-strand RNA genome. Its genome consists of four main open...

